These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8303687)

  • 1. Platelets in essential hypertension.
    Nityanand S; Pande I; Bajpai VK; Singh L; Chandra M; Singh BN
    Thromb Res; 1993 Dec; 72(5):447-54. PubMed ID: 8303687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet activation by 2-(4-bromo-2,3-dioxobutylthio)adenosine 5'-diphosphate is mediated by its binding to a putative ADP receptor, aggregin.
    Puri RN; Colman RF; Colman RW
    Eur J Biochem; 1996 Mar; 236(3):862-70. PubMed ID: 8665907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ultrastructural changes of platelets during ADP- stimulated aggregation (in the presence of fibrinogen)].
    Belitser NV; Anishchuk MG; Pozdniakova TM; Gorkun OV
    Tsitol Genet; 1989; 23(3):3-7. PubMed ID: 2773059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggregation of platelets in whole blood from children with pulmonary hypertension.
    Lopes AA; Maeda NY; Ebaid M; Chamone DA
    Int J Cardiol; 1990 Aug; 28(2):173-8. PubMed ID: 2394522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-density lipoprotein enhances platelet activation in parallel with the height of blood pressure.
    Fetkovska N; Amstein R; Ferracin F; Bühler FR; Pletscher A
    J Hypertens Suppl; 1988 Dec; 6(4):S646-8. PubMed ID: 3241277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colloidal gold labelling of fibrinogen receptors in epinephrine- and ADP-activated platelet suspensions.
    Oliver JA; Albrecht RM
    Scanning Microsc; 1987 Jun; 1(2):745-56. PubMed ID: 3616571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphological changes of platelets during the process of platelet aggregation in gray platelet syndrome.
    Mori K; Suzuki S; Sugai K; Akutsu Y; Ishikawa M; Sakai H
    Tohoku J Exp Med; 1986 Aug; 149(4):425-36. PubMed ID: 3775766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fosinopril reduces ADP-induced platelet aggregation in hypertensive patients.
    Keidar S; Oiknine J; Leiba A; Shapira C; Leiba M; Aviram M
    J Cardiovasc Pharmacol; 1996 Feb; 27(2):183-6. PubMed ID: 8720415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of scanning electron microscopy to study structural-functional relationships in normal and diseased platelets.
    Mattson JC
    Scan Electron Microsc; 1985; (Pt 1):357-91. PubMed ID: 3890145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shape change and aggregation of blood platelets: interaction between the effects of adenosine and diphosphate, 5-hydroxytryptamine and adrenaline.
    Michal F; Motamed M
    Br J Pharmacol; 1976 Feb; 56(2):209-18. PubMed ID: 1252669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenaline and adenosine diphosphate-induced platelet aggregation require shape change. Importance of pseudopods.
    Milton JG; Frojmovic MM
    J Lab Clin Med; 1984 Nov; 104(5):805-15. PubMed ID: 6387013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of phosphorylation/dephosphorylation reactions in the function of blood platelets.
    Gerrard JM; Beattie LL; Israels SJ; Park J
    Agents Actions Suppl; 1986; 20():129-45. PubMed ID: 3101441
    [No Abstract]   [Full Text] [Related]  

  • 13. Platelet aggregation studies in whole human blood.
    Saniabadi AR; Lowe GD; Forbes CD; Prentice CR; Barbenel JC
    Thromb Res; 1983 Jun; 30(6):625-32. PubMed ID: 6412393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5HT2-receptors and serotonin release: their role in human platelet aggregation.
    Cerrito F; Lazzaro MP; Gaudio E; Arminio P; Aloisi G
    Life Sci; 1993; 53(3):209-15. PubMed ID: 8321084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of angiotensin II and endothelin-1 on platelet aggregation and cytosolic pH and free Ca2+ concentrations in essential hypertension.
    Touyz RM; Schiffrin EL
    Hypertension; 1993 Dec; 22(6):853-62. PubMed ID: 8244517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cerastobin, a thrombinlike enzyme from Cerastes vipera (Egyptian sand snake) venom, on human platelets.
    Farid TM; Tu AT; el-Asmar MF
    Haemostasis; 1990; 20(5):296-304. PubMed ID: 1963167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of the kinetics of ADP-triggered platelet shape change.
    Hantgan RR
    Blood; 1984 Oct; 64(4):896-906. PubMed ID: 6383500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet calcium and quenched-flow aggregation kinetics in essential hypertension.
    Taylor MA; Ayers CR; Gear AR
    Hypertension; 1989 Jun; 13(6 Pt 1):558-66. PubMed ID: 2525522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of platelet glycoprotein IIb-IIIa receptor expression and fibrinogen binding. II. Quantal activation parallels platelet capture in stir-associated microaggregation.
    Frojmovic MM; Mooney RF; Wong T
    Biophys J; 1994 Nov; 67(5):2069-75. PubMed ID: 7858144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet cytoskeleton: immunofluorescence studies on ADP and collagen-activated platelets.
    Billett HH; Jenkins CS; Maimon JJ; Spaet TH; Puszkin EG
    J Lab Clin Med; 1984 Apr; 103(4):534-48. PubMed ID: 6421971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.